Novo Nordisk breached Clause 5.1 after listing an 0845 number for side-effect reporting on Saxenda patient website without call-cost information (AUTH/3545/7/21)

📅 8 March 2026 | 🖉 Dr Anzal Qurbain
📊

Key facts

CaseAUTH/3545/7/21
CompanyNovo Nordisk
ComplainantConcerned UK health professional
Product / contextSaxenda (liraglutide) patient website
IssueUse of an 0845 business-rate number for side-effect reporting on a patient webpage without written call-cost information
Applicable Code2021
Complaint received22 July 2021
Case completed8 September 2021
Breach clausesClause 5.1
No breach clausesClause 6.1
SanctionsUndertaking received; additional sanctions not stated
AppealNo appeal

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
đź“‹

What happened

  • A UK health professional complained that the Saxenda (liraglutide) patient website (www.saxenda.co.uk) listed an 0845 telephone number under “Reporting of side effects” for reporting adverse events to Novo Nordisk.
  • The complainant referenced a prior PMCPA case (AUTH/3281/11/19) about business-rate numbers being used for medical information enquiries without making call costs clear.
  • The Saxenda webpage text included: “Adverse events should also be reported to Novo Nordisk Limited (Telephone Novo Nordisk Customer Care Centre 0845 6005055).”
  • Novo Nordisk said 0845 was a business/service-rate number (not a premium-rate number) and that it offered multiple contact routes including a freephone number.
  • Novo Nordisk stated that callers to the 0845 number heard a recorded message explaining the call would be charged at the caller’s network access charge and offering an alternative freephone number (0800 0232573).
  • The Panel considered that many people perceive 0845 numbers as incurring extra cost and that this perception could deter callers—particularly problematic for patient safety and adverse event reporting.
  • The Panel noted the Saxenda website did not state call-cost information alongside the 0845 number, meaning some users might not call and therefore would never hear the message offering the freephone alternative.
⚖️

Outcome

  • Breach of Clause 5.1 (2021 Code).
  • No breach of Clause 6.1 (2021 Code) (Panel did not consider it relevant to the allegation).
  • No appeal.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
ÂŁ249/year
Annual — save £99
or
ÂŁ29/mo
Monthly
Join Now — Instant Access

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free